Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Let me know

<< Previous

Bullboard Posts

Next >>

Comment by Forestviewon Aug 19, 2021 5:41pm

168 Views

Post# 33734968

RE:RE:Let me know

Apparently Joe Stauffer's son goes on Yahoo Finance's chat board. But, he was quick to make that claim, so I find i fishy.

MasterAlgae wrote: The only thing that would make it better is if one of your parents was a director of Antibe!

Rarbar99 wrote: Let me know if the image isn't showing up, I'll post it on another website. Still says 0 views so I'm thinking it's been filtered https://ibb.co/XkZfMxB